Single cell transcriptome profiling of aqueous humor outflow development for discovery of novel childhood glaucoma genes
房水流出发育的单细胞转录组分析以发现新的儿童青光眼基因
基本信息
- 批准号:10510279
- 负责人:
- 金额:$ 23.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-01 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:ANGPT1 geneAddressAffectAgeAmericanAnimalsAqueous HumorArchitectureAtlasesBiological AssayBiologyBlindnessCYP1B1 geneCandidate Disease GeneCellsCharacteristicsChildChildhoodClinical ManagementComplexCorneaDataData SetDevelopmentDevelopmental BiologyDiagnostic testsDiseaseDrainage procedureExpression ProfilingEyeEye DevelopmentEye EnucleationEye diseasesFailureFamilyFemaleGenderGene ExpressionGene set enrichment analysisGenesGeneticGenetic CounselingGenomeGlaucomaGoalsHumanIn Situ HybridizationInbreedingIndividualInfantKnowledgeLinkLiquid substanceMelaninsModelingMoldsMolecularMolecular DiseaseMorphologyMusMutationOcular HypertensionOperative Surgical ProceduresOptic NerveOutcomePainPathogenesisPathogenicityPathway interactionsPharmacologic SubstancePhysiologic Intraocular PressurePopulationPopulation HeterogeneityPositioning AttributePreparationProteinsRNARattusRegulationResearchResource SharingResourcesST13 geneSamplingSex BiasStretchingStructureStructure of sinus venosus of scleraTechnologyTestingTextTissue DifferentiationTissue-Specific Gene ExpressionTissuesTrabecular meshwork structureTranscriptVariantVisualalbino ratanterior chamberbasecell typecohortconvictdesigndifferential expressiondisabilityeffective therapyexomeexome sequencingexperimental groupgene functiongenetic variantimprovedin silicomalemolecular markernerve damagenoveloverexpressionpopulation basedprimary congenital glaucomapublic health relevanceselective expressionsexsingle-cell RNA sequencingtherapy developmenttranscriptome
项目摘要
Project Summary / Abstract
Primary congenital glaucoma (PCG) is a devastating eye disorder that affects infants and demonstrates an
overall gender bias towards males (1.5:1). It is triggered by elevated intraocular pressure (IOP) which leads to
painful enlargement of the eye and severe tissue damage, often resulting in blindness and eye enucleation in a
significant proportion of children. All known causes are due to failure to correctly develop the aqueous humor
outflow (AHO) structures important for regulation of fluid drainage - primarily the trabecular meshwork (TM)
and Schlemm’s canal (SC). Mutations in 4 genes, CYP1B1, LTBP2, TEK, and ANGPT1, are currently known to
cause 25% of PCG in diverse populations. CYP1B1 mutations alone account for 20% of cases and effect more
females (1:2). These known genes are all important for development of the TM and/or SC. Despite global
exome sequencing efforts to date, the mechanisms underlying the remaining 75% cases remain undiscovered
and male sex-linked genes have yet to be identified. We hypothesize that the elusive genes underlying
PCG are critical for and therefore expressed during the development of the AHO pathway, but we
currently lack a comprehensive knowledge of gene expression during the formation of these important
ocular structures. We propose that the identification of these vital pathways will enable discovery of
the elusive molecular mechanisms of PCG, which in-turn will permit the development of treatments
aimed at the underlying disease biology. Until recently, the feasibility of expression profiling the AHO
pathway was limited due to its complex architecture and variety of cell types. Now, single-cell RNA sequencing
(scRNAseq) technology has enabled such studies by molecular separation of different cell populations based
on expression profiles at the single-cell level. To address our central hypothesis, we will profile transcriptomes
from all cell types within the AHO pathway throughout of its development utilizing scRNAseq. Rat tissues will
be utilized because they share with humans all major stages and morphological characteristics of AHO
pathway development, can be bred to defined developmental ages, and will supply significantly larger tissues
versus mice for scRNAseq profiling. We will generate separate datasets from male and female tissues at 6
different ages (P4, P8, P16, P48, P80, and P180), enabling identification of differentially expressed genes and
pathways specific to each cell type, developmental stage, and gender. We will then use this resource to reveal
likely disease-causing gene variants within existing exome sequencing data from molecularly unsolved PCG
cases. Candidate disease gene expression within the developing AHO structures will be confirmed by in situ
hybridization (RNAscope) studies. Finally, wild-type and variant mini-genes will be created to test the effect of
each candidate disease-causing variant on the gene’s function using a variety of cell-based assays.
项目概要/摘要
原发性先天性青光眼 (PCG) 是一种毁灭性的眼部疾病,会影响婴儿并表现出一种
总体性别偏向男性(1.5:1)。它是由眼内压(IOP)升高引发的,导致
眼睛疼痛性增大和严重的组织损伤,通常导致失明和眼球摘除
儿童所占比例很大。所有已知的原因都是由于房水未能正确发育所致
流出 (AHO) 结构对于调节液体引流很重要 - 主要是小梁网 (TM)
和施累姆氏管 (SC)。目前已知 CYP1B1、LTBP2、TEK 和 ANGPT1 4 个基因的突变会导致
不同人群中 25% 的 PCG 均由其引起。仅 CYP1B1 突变就占病例的 20%,且影响更大
女性(1:2)。这些已知基因对于 TM 和/或 SC 的发育都很重要。尽管全球
迄今为止,外显子组测序工作尚未发现其余 75% 病例的潜在机制
男性的性连锁基因尚未确定。我们假设潜在的难以捉摸的基因
PCG 对于 AHO 途径的发展至关重要,因此在 AHO 途径的发展过程中表达,但我们
目前缺乏对这些重要基因形成过程中基因表达的全面了解
眼部结构。我们建议识别这些重要途径将有助于发现
PCG 难以捉摸的分子机制,这反过来将允许治疗方法的开发
针对潜在的疾病生物学。直到最近,AHO 表达谱分析的可行性
由于其复杂的结构和多种细胞类型,该途径受到限制。现在,单细胞RNA测序
(scRNAseq) 技术通过基于不同细胞群的分子分离来实现此类研究
单细胞水平的表达谱。为了解决我们的中心假设,我们将分析转录组
利用 scRNAseq 从 AHO 途径的整个开发过程中的所有细胞类型中提取数据。大鼠组织将
被利用是因为它们与人类共享 AHO 的所有主要阶段和形态特征
途径发育,可以培育到规定的发育年龄,并且将提供更大的组织
与小鼠进行 scRNAseq 分析。我们将在 6 时从男性和女性组织中生成单独的数据集
不同年龄(P4、P8、P16、P48、P80 和 P180),能够识别差异表达基因和
每种细胞类型、发育阶段和性别特有的途径。然后我们将使用此资源来揭示
来自分子未解的 PCG 的现有外显子组测序数据中可能致病的基因变异
案例。正在发育的 AHO 结构内的候选疾病基因表达将通过原位证实
杂交(RNAscope)研究。最后,将创建野生型和变异型小基因来测试其效果
使用各种基于细胞的检测来分析基因功能的每个候选致病变异。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Stuart William James Tompson其他文献
Stuart William James Tompson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Stuart William James Tompson', 18)}}的其他基金
Single cell transcriptome profiling of aqueous humor outflow development for discovery of novel childhood glaucoma genes
房水流出发育的单细胞转录组分析以发现新的儿童青光眼基因
- 批准号:
10682543 - 财政年份:2022
- 资助金额:
$ 23.33万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 23.33万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 23.33万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 23.33万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 23.33万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 23.33万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 23.33万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 23.33万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 23.33万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 23.33万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 23.33万 - 项目类别:
Research Grant














{{item.name}}会员




